Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- Epidemiology of HIV-related CVD in developing countries is largely unknown, although long-term data in the ART era are accumulating[Mutimura 2008a; Mutimura 2008b; Syed 2013; Almodovar 2010]
- Prevention and management of CVD in resource-limited settings is hindered by lack of laboratory infrastructure and specialty management
- Risk-factor reduction can be challenging because of the stresses of extreme poverty in managing lifestyle changes
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content